Flavonoids Targeting HIF-1: Implications on Cancer Metabolism

<p dir="ltr">Tumor hypoxia is described as an oxygen deprivation in malignant tissue. The hypoxic condition is a consequence of an imbalance between rapidly proliferating cells and a vascularization that leads to lower oxygen levels in tumors. Hypoxia-inducible factor 1 (HIF-1) is an...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Marek Samec (14727823) (author)
مؤلفون آخرون: Alena Liskova (11008851) (author), Lenka Koklesova (18102994) (author), Sandra Mersakova (16493790) (author), Jan Strnadel (293905) (author), Karol Kajo (5926877) (author), Martin Pec (18877819) (author), Kevin Zhai (18877843) (author), Karel Smejkal (11912513) (author), Sepideh Mirzaei (16935921) (author), Kiavash Hushmandi (13025697) (author), Milad Ashrafizadeh (12342797) (author), Luciano Saso (404294) (author), Aranka Brockmueller (11064675) (author), Mehdi Shakibaei (325455) (author), Dietrich Büsselberg (11008857) (author), Peter Kubatka (11008854) (author)
منشور في: 2021
الموضوعات:
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
_version_ 1864513512385019904
author Marek Samec (14727823)
author2 Alena Liskova (11008851)
Lenka Koklesova (18102994)
Sandra Mersakova (16493790)
Jan Strnadel (293905)
Karol Kajo (5926877)
Martin Pec (18877819)
Kevin Zhai (18877843)
Karel Smejkal (11912513)
Sepideh Mirzaei (16935921)
Kiavash Hushmandi (13025697)
Milad Ashrafizadeh (12342797)
Luciano Saso (404294)
Aranka Brockmueller (11064675)
Mehdi Shakibaei (325455)
Dietrich Büsselberg (11008857)
Peter Kubatka (11008854)
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author_facet Marek Samec (14727823)
Alena Liskova (11008851)
Lenka Koklesova (18102994)
Sandra Mersakova (16493790)
Jan Strnadel (293905)
Karol Kajo (5926877)
Martin Pec (18877819)
Kevin Zhai (18877843)
Karel Smejkal (11912513)
Sepideh Mirzaei (16935921)
Kiavash Hushmandi (13025697)
Milad Ashrafizadeh (12342797)
Luciano Saso (404294)
Aranka Brockmueller (11064675)
Mehdi Shakibaei (325455)
Dietrich Büsselberg (11008857)
Peter Kubatka (11008854)
author_role author
dc.creator.none.fl_str_mv Marek Samec (14727823)
Alena Liskova (11008851)
Lenka Koklesova (18102994)
Sandra Mersakova (16493790)
Jan Strnadel (293905)
Karol Kajo (5926877)
Martin Pec (18877819)
Kevin Zhai (18877843)
Karel Smejkal (11912513)
Sepideh Mirzaei (16935921)
Kiavash Hushmandi (13025697)
Milad Ashrafizadeh (12342797)
Luciano Saso (404294)
Aranka Brockmueller (11064675)
Mehdi Shakibaei (325455)
Dietrich Büsselberg (11008857)
Peter Kubatka (11008854)
dc.date.none.fl_str_mv 2021-01-03T03:00:00Z
dc.identifier.none.fl_str_mv 10.3390/cancers13010130
dc.relation.none.fl_str_mv https://figshare.com/articles/journal_contribution/Flavonoids_Targeting_HIF-1_Implications_on_Cancer_Metabolism/26095738
dc.rights.none.fl_str_mv CC BY 4.0
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Biological sciences
Biochemistry and cell biology
Biomedical and clinical sciences
Oncology and carcinogenesis
cancer
Warburg effect
HIF-1
flavonoids
dc.title.none.fl_str_mv Flavonoids Targeting HIF-1: Implications on Cancer Metabolism
dc.type.none.fl_str_mv Text
Journal contribution
info:eu-repo/semantics/publishedVersion
text
contribution to journal
description <p dir="ltr">Tumor hypoxia is described as an oxygen deprivation in malignant tissue. The hypoxic condition is a consequence of an imbalance between rapidly proliferating cells and a vascularization that leads to lower oxygen levels in tumors. Hypoxia-inducible factor 1 (HIF-1) is an essential transcription factor contributing to the regulation of hypoxia-associated genes. Some of these genes modulate molecular cascades associated with the Warburg effect and its accompanying pathways and, therefore, represent promising targets for cancer treatment. Current progress in the development of therapeutic approaches brings several promising inhibitors of HIF-1. Flavonoids, widely occurring in various plants, exert a broad spectrum of beneficial effects on human health, and are potentially powerful therapeutic tools against cancer. Recent evidences identified numerous natural flavonoids and their derivatives as inhibitors of HIF-1, associated with the regulation of critical glycolytic components in cancer cells, including pyruvate kinase M2(PKM2), lactate dehydrogenase (LDHA), glucose transporters (GLUTs), hexokinase II (HKII), phosphofructokinase-1 (PFK-1), and pyruvate dehydrogenase kinase (PDK). Here, we discuss the results of most recent studies evaluating the impact of flavonoids on HIF-1 accompanied by the regulation of critical enzymes contributing to the Warburg phenotype. Besides, flavonoid effects on glucose metabolism via regulation of HIF-1 activity represent a promising avenue in cancer-related research. At the same time, only more-in depth investigations can further elucidate the mechanistic and clinical connections between HIF-1 and cancer metabolism.</p><h2>Other Information</h2><p dir="ltr">Published in: Cancers<br>License: <a href="https://creativecommons.org/licenses/by/4.0/" target="_blank">https://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.3390/cancers13010130" target="_blank">https://dx.doi.org/10.3390/cancers13010130</a></p>
eu_rights_str_mv openAccess
id Manara2_caea7c3366f822382de80279810ecd4e
identifier_str_mv 10.3390/cancers13010130
network_acronym_str Manara2
network_name_str Manara2
oai_identifier_str oai:figshare.com:article/26095738
publishDate 2021
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv CC BY 4.0
spelling Flavonoids Targeting HIF-1: Implications on Cancer MetabolismMarek Samec (14727823)Alena Liskova (11008851)Lenka Koklesova (18102994)Sandra Mersakova (16493790)Jan Strnadel (293905)Karol Kajo (5926877)Martin Pec (18877819)Kevin Zhai (18877843)Karel Smejkal (11912513)Sepideh Mirzaei (16935921)Kiavash Hushmandi (13025697)Milad Ashrafizadeh (12342797)Luciano Saso (404294)Aranka Brockmueller (11064675)Mehdi Shakibaei (325455)Dietrich Büsselberg (11008857)Peter Kubatka (11008854)Biological sciencesBiochemistry and cell biologyBiomedical and clinical sciencesOncology and carcinogenesiscancerWarburg effectHIF-1flavonoids<p dir="ltr">Tumor hypoxia is described as an oxygen deprivation in malignant tissue. The hypoxic condition is a consequence of an imbalance between rapidly proliferating cells and a vascularization that leads to lower oxygen levels in tumors. Hypoxia-inducible factor 1 (HIF-1) is an essential transcription factor contributing to the regulation of hypoxia-associated genes. Some of these genes modulate molecular cascades associated with the Warburg effect and its accompanying pathways and, therefore, represent promising targets for cancer treatment. Current progress in the development of therapeutic approaches brings several promising inhibitors of HIF-1. Flavonoids, widely occurring in various plants, exert a broad spectrum of beneficial effects on human health, and are potentially powerful therapeutic tools against cancer. Recent evidences identified numerous natural flavonoids and their derivatives as inhibitors of HIF-1, associated with the regulation of critical glycolytic components in cancer cells, including pyruvate kinase M2(PKM2), lactate dehydrogenase (LDHA), glucose transporters (GLUTs), hexokinase II (HKII), phosphofructokinase-1 (PFK-1), and pyruvate dehydrogenase kinase (PDK). Here, we discuss the results of most recent studies evaluating the impact of flavonoids on HIF-1 accompanied by the regulation of critical enzymes contributing to the Warburg phenotype. Besides, flavonoid effects on glucose metabolism via regulation of HIF-1 activity represent a promising avenue in cancer-related research. At the same time, only more-in depth investigations can further elucidate the mechanistic and clinical connections between HIF-1 and cancer metabolism.</p><h2>Other Information</h2><p dir="ltr">Published in: Cancers<br>License: <a href="https://creativecommons.org/licenses/by/4.0/" target="_blank">https://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.3390/cancers13010130" target="_blank">https://dx.doi.org/10.3390/cancers13010130</a></p>2021-01-03T03:00:00ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.3390/cancers13010130https://figshare.com/articles/journal_contribution/Flavonoids_Targeting_HIF-1_Implications_on_Cancer_Metabolism/26095738CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/260957382021-01-03T03:00:00Z
spellingShingle Flavonoids Targeting HIF-1: Implications on Cancer Metabolism
Marek Samec (14727823)
Biological sciences
Biochemistry and cell biology
Biomedical and clinical sciences
Oncology and carcinogenesis
cancer
Warburg effect
HIF-1
flavonoids
status_str publishedVersion
title Flavonoids Targeting HIF-1: Implications on Cancer Metabolism
title_full Flavonoids Targeting HIF-1: Implications on Cancer Metabolism
title_fullStr Flavonoids Targeting HIF-1: Implications on Cancer Metabolism
title_full_unstemmed Flavonoids Targeting HIF-1: Implications on Cancer Metabolism
title_short Flavonoids Targeting HIF-1: Implications on Cancer Metabolism
title_sort Flavonoids Targeting HIF-1: Implications on Cancer Metabolism
topic Biological sciences
Biochemistry and cell biology
Biomedical and clinical sciences
Oncology and carcinogenesis
cancer
Warburg effect
HIF-1
flavonoids